Clinical trials

  • DASATINIB for Acute lymphoblastic leukemia (relapsed or refractory) | Precursor B-cell lymphoblastic lymphoma/leukaemia (relapsed or refractory) | Precursor T-cell lymphoblastic lymphoma/leukaemia (relapsed or refractory)
  • SECUKINUMAB for Hidradenitis suppurativa
  • Montelukast for Erosive hand osteoarthritis
  • KISIMA-02 for Pancreatic ductal adenocarcinoma (KRAS G12D/G12V)
  • RADIUM-224 ADSORBED IN CALCIUM CARBONATE MICROPARTICLES for High-grade serous ovarian cancer|High-grade endometrioid ovarian cancer|Primary peritoneal cancer|Peritoneal carcinomatosis
  • ATUMELNANT for Classic congenital adrenal hyperplasia
  • [18F]META-FLUOROBENZYLGUANIDINE for Neuroblastoma
  • INEBILIZUMAB for Immunoglobulin G4-related disease
  • SARUPARIB for Metastatic castration-sensitive prostate cancer
  • Betamethasone dipropionate; Clotrimazole for Candidiasis of the skin
  • 1-[6-ETHYL-8-FLUORO-4-METHYL-3-(3-METHYL-1,2,4-OXADIAZOL-5-YL)QUINOLIN-2-YL]-N-(OXAN-4-YL)PIPERIDIN-4-AMINE for Major Depressive Disorder
  • SACITUZUMAB TIRUMOTECAN for Non-small cell lung cancer | Nonsquamous non-small cell lung cancer